Cayman Chem

Ann Arbor, United States Founded: 1980 • Age: 46 yrs
Bioreagents and assay kits are developed, with preclinical services provided.

About Cayman Chem

Cayman Chem is a company based in Ann Arbor (United States) founded in 1980.. The company has 309 employees as of December 31, 2022. Cayman Chem has completed 1 acquisition, including Matreya. Cayman Chem operates in a competitive market with competitors including Abcam, Abzena, Patheon, Syngene and Piramal Group, among others.

  • Headquarter Ann Arbor, United States
  • Employees 309 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cayman Chemical Company, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.7 M (USD), Grant

    Sep 23, 2021

  • Investors
    HHS

    & 1 more

  • Employee Count
    309

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Cayman Chem
Headcount 200-500
Employee Profiles 79
Employee Profiles
People
Dana Sanford
VP, Operations & Production
People
Cid Belser
Director, IT
People
Sara Sipple
Senior Project Manager
People
Hillary Karas
CS Order Specialist Supervisor

Unlock access to complete

Funding Insights of Cayman Chem

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $1.7M
  • First Round

    (30 Sep 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2021 Amount Grant - Cayman Chem Valuation

investors

Sep, 2021 Amount Grant - Cayman Chem Valuation

investors

HHS
Sep, 2019 Amount Grant - Cayman Chem Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cayman Chem

Cayman Chem has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Institute of Dental and Craniofacial Research. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Research on dental and craniofacial health is conducted.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cayman Chem

Cayman Chem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Matreya. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Lipids, biochemicals, and other chemicals are manufactured and supplied.
1998
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Cayman Chem

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cayman Chem Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cayman Chem

Cayman Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Abzena, Patheon, Syngene and Piramal Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Provider of antibody discovery, cell line development, and bio analytics services
domain founded_year HQ Location
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
domain founded_year HQ Location
Provider of contract research and manufacturing services for both small molecules and biologics
domain founded_year HQ Location
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
domain founded_year HQ Location
Developer of biosimilars, vaccines and natural products
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Cayman Chem

When was Cayman Chem founded?

Cayman Chem was founded in 1980 and raised its 1st funding round 37 years after it was founded.

Where is Cayman Chem located?

Cayman Chem is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

How many employees does Cayman Chem have?

As of Dec 31, 2022, the latest employee count at Cayman Chem is 309.

What does Cayman Chem do?

Cayman Chem was founded in 1980 in Ann Arbor, United States, focusing on the biotechnology sector. Kits and reagents for research applications, including antibodies, assay kits, biochemicals, and proteins, are developed. Services encompass bioanalytical work, custom antibody production, bioenergetics, organic synthesis, epigenetic screening and profiling, protein production and purification, and medicinal chemistry. Preclinical API development, manufacturing, chemical synthesis, analysis, bioanalysis, and forensic services are also offered.

Who are the top competitors of Cayman Chem?

Cayman Chem's top competitors include Abcam, Abzena and Syngene.

How many acquisitions has Cayman Chem made?

Cayman Chem has made 1 acquisition, including Matreya.

Who are Cayman Chem's investors?

Cayman Chem has 2 investors. Key investors include HHS, and National Institute of Dental and Craniofacial Research.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available